Craft
Hanmi Pharmaceutical

Hanmi Pharmaceutical

Revenue

₩1.2 T

FY, 2021

Market Capitalization

₩3.2 T

2023-01-27

Hanmi Pharmaceutical Summary

Company summary

Overview
Hanmi Pharmaceutical is a company focused on the development and commercialization of pharmaceutical products. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases.
Type
Public
Status
Active
Founded
1973
HQ
Seoul, KR | view all locations
Website
http://www.hanmipharm.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Seoul, Seoul HQ

    Korea (Republic of)

    14 Wiryeseong-daero, Songpa-gu

Hanmi Pharmaceutical Financials

Summary financials

Revenue (Q2, 2022)
₩317.1B
Gross profit (Q2, 2022)
₩168.9B
Net income (Q2, 2022)
₩22.7B
Cash (Q2, 2022)
₩154.1B
EBIT (Q2, 2022)
₩28.4B
Enterprise value
$3.6T

Footer menu